{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:41:36Z","timestamp":1790383296547,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00192-024-05726-2","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T07:02:56Z","timestamp":1707375776000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Use of Methenamine for Urinary Tract Infection Prophylaxis: Systematic Review of Recent Evidence"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-7496","authenticated-orcid":false,"given":"Spencer M.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-5948","authenticated-orcid":false,"given":"Jamie N.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton B.","family":"Nance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9954-4846","authenticated-orcid":false,"given":"Mary L.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"5726_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"5726_CR2","unstructured":"Interagency Coordination Group on Antimicrobial Resistance. No time to wait: Securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations. 2019. Available from: https:\/\/www.who.int\/docs\/default-source\/documents\/no-time-to-wait-securing-the-future-from-drug-resistant-infections-en.pdf. Accessed 10 Jan 2023."},{"issue":"Suppl 4","key":"5726_CR3","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.1086\/382690","volume":"38","author":"DL Paterson","year":"2004","unstructured":"Paterson DL. Collateral damage from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(Suppl 4):S341\u20135.","journal-title":"Clin Infect Dis"},{"key":"5726_CR4","doi-asserted-by":"publisher","first-page":"888205","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health. 2022;10:888205.","journal-title":"Front Public Health"},{"issue":"1","key":"5726_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1\u201313.","journal-title":"Infect Dis Clin North Am"},{"key":"5726_CR6","first-page":"Doc01","volume":"10","author":"KG Naber","year":"2022","unstructured":"Naber KG, Tir\u00e1n-Saucedo J, Wagenlehner FME, RECAP group. Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS. Infect Dis. 2022;10:Doc01.","journal-title":"Infect Dis"},{"issue":"1","key":"5726_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13756-022-01170-3","volume":"11","author":"J Shafrin","year":"2022","unstructured":"Shafrin J, Marijam A, Joshi AV, et al. Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records. Antimicrob Resist Infect Control. 2022;11(1):133.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"5726_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ajog.2021.04.218","volume":"225","author":"JL Langner","year":"2021","unstructured":"Langner JL, Chiang KF, Stafford RS. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women. Am J Obstet Gynecol. 2021;225(3):272.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5726_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JU.0000000000000296","volume":"202","author":"J Anger","year":"2019","unstructured":"Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline. J Urol. 2019;202(2):282\u20139.","journal-title":"J Urol"},{"issue":"4","key":"5726_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/JU.0000000000002888","volume":"208","author":"BR Bixler","year":"2022","unstructured":"Bixler BR, Anger JT. Updates to recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline. J Urol. 2022;208(4):754\u20136.","journal-title":"J Urol"},{"issue":"5","key":"5726_CR11","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u201320.","journal-title":"Clin Infect Dis"},{"key":"5726_CR12","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciz021","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68:e83\u2013110.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"5726_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bju.15756","volume":"130","author":"M Kwok","year":"2022","unstructured":"Kwok M, McGeorge S, Mayer-Coverdale J, et al. Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int. 2022;130(Suppl 3):11\u201322.","journal-title":"BJU Int"},{"key":"5726_CR14","unstructured":"Hiprex (methenamine) [prescribing information]. Parsippany, NJ: Validus Pharmaceuticals LLC. 2021. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c8ddaa11-5753-46eb-8bd4-8f1d874a3ec4. Accessed 23 Jan 2024."},{"key":"5726_CR15","volume-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"GG Briggs","year":"2022","unstructured":"Briggs GG, Towers C, Forinash AB. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 12th ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2022.","edition":"12"},{"issue":"10","key":"5726_CR16","first-page":"CD003265","volume":"10","author":"BS Lee","year":"2012","unstructured":"Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10):CD003265.","journal-title":"Cochrane Database Syst Rev"},{"key":"5726_CR17","doi-asserted-by":"publisher","first-page":"e1011405","DOI":"10.1371\/journal.ppat.1011405","volume":"19","author":"C Gu","year":"2023","unstructured":"Gu C, Ackerman AL. An oldie but a goodie: methenamine as a nonantibiotic solution to the prevention of recurrent urinary tract infections. PLoS Pathog. 2023;19:e1011405.","journal-title":"PLoS Pathog"},{"issue":"6","key":"5726_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MOU.0000000000001108","volume":"33","author":"S Kale","year":"2023","unstructured":"Kale S, Somani BK. The resurgence of methenamine hippurate in the prevention of recurrent UTIs in women\u2014a systematic review. Curr Opin Urol. 2023;33(6):488\u201396. https:\/\/doi.org\/10.1097\/MOU.0000000000001108.","journal-title":"Curr Opin Urol"},{"key":"5726_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139.","journal-title":"Ann Intern Med"},{"key":"5726_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1\u201312.","journal-title":"Control Clin Trials"},{"key":"5726_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712\u20136.","journal-title":"ANZ J Surg"},{"issue":"3","key":"5726_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00192-021-04849-0","volume":"33","author":"C Botros","year":"2022","unstructured":"Botros C, Lozo S, Iyer S, et al. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial. Int Urogynecol J. 2022;33(3):571\u201380.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"5726_CR23","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1097\/SPV.0000000000001147","volume":"28","author":"TY Tam","year":"2022","unstructured":"Tam TY, Aldrich ER, Crisp CC, Yook E, Yeung J, Pauls RN. Methenamine hippurate with cranberry capsules versus cranberry alone for urinary tract infection prevention in a short-term indwelling Foley catheter population after urogynecologic surgery: a double-blinded randomized controlled trial. Female Pelvic Med Reconstr Surg. 2022;28(3):e55\u201361.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"5726_CR24","doi-asserted-by":"publisher","first-page":"e068229","DOI":"10.1136\/bmj-2021-0068229","volume":"376","author":"C Harding","year":"2022","unstructured":"Harding C, Mossop H, Homer T, et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ. 2022;376:e068229.","journal-title":"BMJ"},{"issue":"3","key":"5726_CR25","doi-asserted-by":"publisher","first-page":"e13063","DOI":"10.1111\/tid.13063","volume":"21","author":"I Hollyer","year":"2019","unstructured":"Hollyer I, Varias F, Ho B, Ison MG. Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: a single center, retrospective study. Transpl Infect Dis. 2019;21(3):e13063.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"5726_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1060028019886308","volume":"54","author":"MS Snellings","year":"2020","unstructured":"Snellings MS, Linnebur SA, Pearson SM, Wallace JI, Saseen JJ, Fixen DR. Effectiveness of methenamine for UTI prevention in older adults. Ann Pharmacother. 2020;54(4):359\u201363.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"5726_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/15269248211064880","volume":"32","author":"H Sweiss","year":"2022","unstructured":"Sweiss H, Bhayana S, Hall R, Nelson J, Kincaide E. Methenamine for recurrent urinary tract infections in solid organ transplantation. Prog Transplant. 2022;32(1):67\u201372.","journal-title":"Prog Transplant"},{"issue":"3","key":"5726_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/02813432.2022.2139363","volume":"40","author":"L Rui","year":"2022","unstructured":"Rui L, Lindbaek M, Gjelstad S. Preventive effect of methenamine in women with recurrent urinary tract infections\u2014a case-control study. Scand J Prim Health Care. 2022;40(3):331\u20138.","journal-title":"Scand J Prim Health Care"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-024-05726-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T06:35:30Z","timestamp":1713335730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-024-05726-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5726"],"URL":"https:\/\/doi.org\/10.1007\/s00192-024-05726-2","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}